secwatch.observer — SEC 8-K summary
======================================

Issuer:     Werewolf Therapeutics, Inc. (HOWL)
CIK:        0001785530
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001193125-25-231953
Event type: regulatory
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Board member Dr. Alon Lazarus dies; Werewolf Therapeutics non-compliant with Nasdaq audit committee rule
--------------------------------------------------------------------------------

- Dr. Alon Lazarus, board member since Aug 2019, passed away on Sep 30, 2025.
- His death reduced the Audit Committee to two members, violating Nasdaq Rule 5605(c)(2) requiring three members.
- Company notified Nasdaq on Oct 2, 2025; cure period runs until next annual meeting or Sep 30, 2026.
- Board plans to appoint an additional independent director to fill the Audit Committee vacancy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1785530/000119312525231953/0001193125-25-231953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1785530/000119312525231953/d12663d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-231953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer